Support teaching, research, and patient care.
Dr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is a leading contributor to the development of CRISPR technology for genome engineering. His lab created the first nuclease-deactivated Cas9 (dCas9) for targeted gene regulation in cells. His lab has since invented a series of CRISPR technologies, including CRISPRi and CRISPRa for targeted gene regulation, epigenome editing, LiveFISH for real-time cell imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a compact CRISPR system for gene therapy, hyperCas12a for multi-gene engineering, and CRISPR antivirals aimed at treating broad RNA viruses. With a broad interest in mammalian synthetic biology, Dr. Qi's lab focuses on epigenome engineering, immune cell engineering, directed evolution, and novel gene therapy. Additionally, they actively investigate the functional role of the human noncoding genome in immunology and neurobiology. Dr. Qi earned his B.S. in Physics and Math from Tsinghua University and Ph.D. in Bioengineering from the University of California, Berkeley. He was a UCSF Systems Biology Fellow. He joined the faculty at Stanford University in 2014.